Skip to main content

Definitive Healthcare earns 2024 Middle Market Leader Award from Boston Business Journal

FRAMINGHAM, Mass., March 14, 2024 (GLOBE NEWSWIRE) — Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it has been named one of the Boston Business Journal’s Middle Market Leaders for 2024, a ranking of the 50 highest growth companies in Massachusetts. This marks the second year in a row that Definitive Healthcare has won this award.

The Boston Business Journal selects the Middle Market Leaders using a weighted index score based on revenue growth from 2020 to 2022. For a company to qualify, it must report annual revenue between $25 million and $1 billion from 2020 to 2022.

From 2020 to 2022, Definitive Healthcare’s total revenue grew from $118.3 million to $222.7 million. At the end of the financial year 2022, the company exited with a 34% year-over-year increase.

“We’re honored to receive the Middle Market Leader recognition from the Boston Business Journal. It’s a reflection of the real-world value we create for our clients every day, thanks to the hard work of our outstanding team,” said Jason Krantz, founder, executive chairman, and interim CEO of Definitive Healthcare. “Our robust Atlas Dataset has empowered thousands of customers to navigate the complex healthcare market with clarity and confidence. As the foundation for our healthcare commercial intelligence, the Atlas Dataset has been instrumental to our financial growth, but more importantly, it has empowered our clients to achieve their commercial goals.”

This latest honor follows a Silver Stevie Award® in the category of Employer of the Year – Health Products and Services. Definitive Healthcare has also been recognized as a top place to work by the Boston Globe, Built In, and Energage.

For the full list of Middle Market Leaders, visit here.

About Definitive Healthcare
At Definitive Healthcare, our mission is to transform data, analytics, and expertise into healthcare commercial intelligence. We help clients uncover the right markets, opportunities, and people, so they can shape tomorrow’s healthcare industry. Our SaaS platform creates new paths to commercial success in the healthcare market, so companies can identify where to go next. Learn more at definitivehc.com.

Media Contact:
Bethany Swackhamer
bswackhamer@definitivehc.com

Investor Relations Contact:
Brian Denyeau
ICR for Definitive Healthcare
brian.denyeau@icrinc.com
646-277-1251

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.